A blood-based test to detect Alzheimer's

( sufficient analytical sensitivity to detect tau in serum )

PleaseHelpSupport Alzheimer's Research Today!
Your Alzheimer's donation will help billionslive without it. Donate online now

Applied NeuroSolutions, Inc. (OTCBB:APSN), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today confirmed, as previously disclosed in July 2009, that it has achieved sufficient analytical sensitivity to detect tau in serum patient samples.

This is a key step in the development of a blood-based test to detect AD at an early stage. Based on a further analysis of the preliminary data, the Company believes additional development of the assay, including optimization and validation in key patient population groups, is necessary to determine the specific sensitivity and specificity performance of the assay. ...http://www.canada.com

Vitamin D recommendations don’t prevent elderly falls

Existing recommendations for vitamin D are inadequate to prevent falls amongst the elderly, according to a new meta-analysis from a team of international scientists. ...http://www.nutraingredients.com

Беларусь ТВ

Posted YVN